KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Net Income towards Common Stockholders (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Net Income towards Common Stockholders readings, the most recent being -$80.8 million for Q4 2025.

  • On a quarterly basis, Net Income towards Common Stockholders rose 24.91% to -$80.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$312.8 million, a 42.83% increase, with the full-year FY2025 number at -$312.8 million, up 42.83% from a year prior.
  • Net Income towards Common Stockholders hit -$80.8 million in Q4 2025 for Ginkgo Bioworks Holdings, roughly flat from -$80.8 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$54.5 million in Q2 2021 to a low of -$1.6 billion in Q4 2021.
  • Median Net Income towards Common Stockholders over the past 5 years was -$169.5 million (2022), compared with a mean of -$284.7 million.
  • Biggest five-year swings in Net Income towards Common Stockholders: crashed 3503.81% in 2021 and later surged 89.22% in 2022.
  • Ginkgo Bioworks Holdings' Net Income towards Common Stockholders stood at -$1.6 billion in 2021, then surged by 89.22% to -$173.1 million in 2022, then decreased by 22.31% to -$211.7 million in 2023, then skyrocketed by 49.2% to -$107.5 million in 2024, then rose by 24.91% to -$80.8 million in 2025.
  • The last three reported values for Net Income towards Common Stockholders were -$80.8 million (Q4 2025), -$80.8 million (Q3 2025), and -$60.3 million (Q2 2025) per Business Quant data.